Mesoblast Ltd. (MESO)
16.82
-0.37
(-2.15%)
USD |
NASDAQ |
Aug 26, 16:00
17.00
+0.18
(+1.07%)
After-Hours: 20:00
Mesoblast 1 Year Total Returns (Daily) : 9.42% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 9.42% |
| August 24, 2026 | 5.25% |
| August 21, 2026 | 12.06% |
| August 20, 2026 | 16.12% |
| August 19, 2026 | 13.14% |
| August 18, 2026 | 4.65% |
| August 17, 2026 | 4.74% |
| August 14, 2026 | -1.67% |
| August 13, 2026 | 8.56% |
| August 12, 2026 | 13.00% |
| August 11, 2026 | 15.10% |
| August 10, 2026 | 10.98% |
| August 07, 2026 | 4.25% |
| August 06, 2026 | -0.26% |
| August 05, 2026 | -4.04% |
| August 04, 2026 | -4.08% |
| August 03, 2026 | -4.61% |
| July 31, 2026 | -7.14% |
| July 30, 2026 | -6.79% |
| July 29, 2026 | -11.36% |
| July 28, 2026 | -9.29% |
| July 27, 2026 | -11.00% |
| July 24, 2026 | -9.84% |
| July 23, 2026 | -0.06% |
| July 22, 2026 | 8.09% |
| Date | Value |
|---|---|
| July 21, 2026 | 12.08% |
| July 20, 2026 | 6.47% |
| July 17, 2026 | 40.36% |
| July 16, 2026 | 57.36% |
| July 15, 2026 | 66.42% |
| July 14, 2026 | 49.87% |
| July 13, 2026 | 45.99% |
| July 10, 2026 | 40.11% |
| July 09, 2026 | 41.10% |
| July 08, 2026 | 41.63% |
| July 07, 2026 | 35.71% |
| July 06, 2026 | 34.18% |
| July 02, 2026 | 32.41% |
| July 01, 2026 | 16.25% |
| June 30, 2026 | 24.24% |
| June 29, 2026 | 24.63% |
| June 26, 2026 | 22.70% |
| June 25, 2026 | 37.44% |
| June 24, 2026 | 48.80% |
| June 23, 2026 | 51.38% |
| June 22, 2026 | 48.54% |
| June 18, 2026 | 22.93% |
| June 17, 2026 | 18.69% |
| June 16, 2026 | 11.79% |
| June 15, 2026 | 16.81% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Immutep Ltd. | -77.54% |
| CSL Ltd. | -7.26% |
| Ceryvyn Therapeutics Ltd. | -99.32% |
| Propanc Biopharma, Inc. | -98.66% |
| Actinogen Medical Ltd. | 9.60% |